Astellas Pharma Vesicare OD gets Japanese approval
Vesicare OD, a muscarine receptor antagonist discovered and developed by Astellas, was approved for an additional formulation of the overactive bladder treatment with the indication of urinary frequency,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.